I
Ibogaine Treatment / dashboard
Emergency: 911 Crisis line: 988 SAMHSA: 1-800-662-4357

Clinical treatment, honestly explained.

For people considering ibogaine-assisted therapy for 7-OH, kratom, or opioid dependence. What it is. How it works. What it costs. Where to go. And the things most clinics don't tell you upfront.

This is education, not endorsement. Ibogaine is not legal in the US and carries real cardiac risk.
i.

What ibogaine is

Mechanism · honestly

A psychoactive alkaloid from the Tabernanthe iboga root that acts on multiple receptor systems simultaneously — which is why it can address opioid dependence where single-mechanism drugs fail.

Used in Central African traditional medicine for generations. Entered Western addiction research in the 1960s. Currently Schedule I in the United States, unscheduled or legally accessible in Mexico, Canada, Costa Rica, Portugal, New Zealand, South Africa, and several other countries where licensed clinics operate.

Ibogaine is not recreational. The experience typically lasts 12–24 hours, involves autobiographical "life review," and is physically demanding. Medical supervision is non-negotiable due to cardiac risks (QT interval prolongation).

The active metabolite, noribogaine, has a 28–49 hour half-life and sustains therapeutic effects for days after the primary experience ends.

Mu-opioid
Modulates opioid receptors in a way that eliminates physical withdrawal within hours, without producing dependence itself.
NMDA
Antagonizes NMDA glutamate receptors — similar mechanism to ketamine. Disrupts rigid habitual circuits.
Serotonin
Blocks serotonin reuptake. Noribogaine sustains this for days, addressing the depressive dimension of withdrawal.
Dopamine
Normalizes D2 receptor density in nucleus accumbens — the reward circuit damaged by chronic substance use.
BDNF / GDNF
Upregulates neurotrophic factors. Opens an 8–12 week neuroplasticity window for integration and behavioral change.
ii.

Treatment phases

What the process looks like
01
Pre-treatment · 2–8 weeks
Medical screening
Cardiac evaluation (EKG, Echo), liver function, psychiatric screening, medication taper plans.
  • QT interval must be within safe range
  • No history of heart disease
  • Taper off SSRIs, benzodiazepines if applicable
  • Long-acting opioids switched to short-acting
02
Onsite · Days 1–2
Acute treatment
Flood dose administered in clinical setting. Continuous cardiac and neurological monitoring throughout.
  • Experience lasts 12–24 hours
  • Physically demanding — nausea, ataxia typical
  • Autobiographical "life review" common
  • Withdrawal eliminated within 2–6 hours
03
Onsite · Days 3–7
Stabilization
Noribogaine active. Energy returning. Integration work begins. Cardiac monitoring continues until QT normalizes.
  • No physical withdrawal return
  • Emotional rawness, fatigue typical
  • First integration therapy sessions
  • Supplement and protocol orientation
04
Post · Weeks 1–4
Neuroplasticity window
BDNF elevated. New habits imprint faster than normal. This is when the work is actually done.
  • Daily supplement protocol
  • Weekly integration therapy
  • Physical recovery (exercise, sleep, nutrition)
  • Some clinics offer 5-MeO-DMT at week 2–4
05
Post · Months 2–6
Long-term integration
Ongoing therapy, community, and lifestyle work. The ibogaine creates the window. Integration determines outcome.
  • Ongoing therapy (monthly at minimum)
  • Community / recovery support
  • Sustained supplement protocol
  • Trigger and relapse prevention work
06
Post · Year 1+
Sustained recovery
Published outcome studies suggest roughly 50–70% sustained abstinence at 1 year when integration is done well — significantly above standard treatment outcomes.
  • Integration work remains critical
  • Boosters uncommon but possible
  • No 7-OH-specific outcome data yet published
  • Relapse ≠ failure — data, not identity
iii.

For 7-OH specifically

What we know · what we don't
7-Hydroxymitragynine · active alkaloid

There are no published clinical trials for ibogaine specifically treating 7-OH / kratom dependence.

The mu-opioid mechanism transfer is pharmacologically sound — ibogaine addresses the opioid component of dependence effectively, and this should translate to 7-OH since 7-OH binds the same receptors (at 13× the potency of morphine).

But kratom's dual alkaloid profile means withdrawal has a stimulant-like component (from mitragynine) that pure opioid withdrawal doesn't have. Ibogaine's effect on this secondary layer is not well studied.

Clinical framework exists — Collin Schwartz authored the only published framework for 7-OH dependence treatment using ibogaine-assisted therapy, based on personal experience and clinical collaboration at Ambio Life Sciences. But a published framework is not the same as peer-reviewed outcome data. Go in informed.

Practical implication: if you're considering ibogaine for 7-OH, choose a clinic that (a) has experience with kratom cases specifically, (b) offers robust integration support for the longer dual-withdrawal PAWS, and (c) doesn't overclaim efficacy.

iv.

Ibogaine vs. other paths

Honest comparison
Factor
Cold turkey (free)
Suboxone MAT
Ibogaine therapy
Cost
$0
$100–400/mo
$8,000–18,000 total
Physical withdrawal duration
7–14 days severe
Suppressed while on it
Eliminated in 2–6h
PAWS duration
8–24 weeks
Deferred to taper period
Compressed to 2–4 weeks
Addresses craving circuits
No — willpower required
Partial (receptor occupation)
Direct neurobiological reset
Addresses adrenergic / mood
No
No
Yes (serotonergic action)
1-year sustained abstinence*
~5–15%
~30–50% (on MAT)
~50–70% with integration
Primary risk
Relapse (high)
Long-term dependence
Cardiac (QT prolongation)
Legal in US
Yes
Yes (Rx)
No — Schedule I
* Outcome data from general opioid populations. No peer-reviewed 7-OH-specific data yet exists. Integration quality is the strongest predictor of outcome across all paths.
v.

What clinics rarely tell you

Reality check
Risk
Cardiac death is real
QT prolongation has caused fatalities in unscreened patients, particularly with undisclosed medications or heart conditions. Non-medical settings have significantly higher mortality. If a clinic doesn't require EKG and echo, leave.
Risk
Not a cure
Ibogaine opens a window. It doesn't close it. Without integration work — therapy, community, lifestyle — relapse rates approach cold turkey numbers. The treatment is the easy part. The six months after are the work.
Caution
Experience is difficult
12–24 hours of intense subjective experience, often with nausea, ataxia, autobiographical memory flooding, and at times distressing content. People frequently describe it as "the hardest thing I've ever done." Not recreational.
Caution
Not legal in US
Schedule I. Reputable treatment requires international travel (Mexico and Canada are most common for US residents). Some underground US options exist but carry significantly higher medical and legal risk.
Reality
Works when everything else failed
For many people who've tried Suboxone, methadone, rehab, and cold turkey multiple times without success, ibogaine produces meaningful change. The published framework exists because clinicians keep seeing this pattern.
Reality
Financing is possible
Some clinics offer payment plans. Insurance does not cover ibogaine treatment, but flexible spending accounts, medical loans, and crowdfunding are common approaches. Ask clinics about their financial assistance options upfront.
vi.

Licensed clinics

Known reputable options
The following clinics operate legally in their respective jurisdictions and are known for rigorous medical protocols. Inclusion is not endorsement — this is a directory for independent research. Always verify medical credentials, screening protocols, and integration support before committing. Prices are approximate and subject to change.
Ambio Life Sciences
Tijuana, Mexico
Clinical framework 5-MeO-DMT 7-OH experience
Affiliated with the Stanford MISTIC trial. Published the only clinical framework for 7-OH-specific treatment. Combined ibogaine + 5-MeO-DMT protocols. Established integration program.
Beond
Cancún, Mexico
Medical-first Concierge model
Hospital-grade medical supervision with 24/7 cardiac monitoring. Known for high-touch concierge experience. Integration program included. Long-established reputation.
~$15,000+ beond.us ↗
Clear Sky Recovery
Playa del Carmen, Mexico
MD-led 20+ years
Founded in 2006. One of the longest-operating ibogaine clinics. Medical team led by US-licensed physicians. Focuses on full ibogaine protocol — traditional approach.
~$8,500–12,000 clearskyibogaine.com ↗
Iboga Quest
Nayarit, Mexico
Traditional-modern blend Retreat format
Coastal retreat setting combining medical screening with ceremonial traditional Bwiti elements. Emphasizes integration through retreat-style community.
New Roots Ibogaine
Cancún, Mexico
Medical protocol Aftercare focus
Focused on opioid dependence specifically. Extended aftercare program including sober living partnerships in the US. Structured integration approach.
Iboga Wellness Center
Costa Rica
Bwiti tradition Plant-based
Operates legally in Costa Rica. Combines Western medical screening with traditional Bwiti spiritual framework. Smaller capacity, retreat format.
Experience Ibogaine
Tijuana / Rosarito, Mexico
Opioid focus Physician-led
Specializes in opioid dependence cases, including long-term methadone and Suboxone taper protocols. Cardiac monitoring non-negotiable. Physician-operated.
Iboga Canada
British Columbia, Canada
Legal in Canada Nurse-practitioner led
Ibogaine is unscheduled in Canada. This clinic operates under medical supervision with Canadian healthcare standards. More accessible for US residents who prefer North America.
~$8,500 CAD+ ibogacanada.com ↗
Awaken Your Soul
Costa Rica
Iboga + 5-MeO-DMT Combined protocol
Offers both ibogaine and 5-MeO-DMT protocols in combined or separate programs. Strong integration emphasis. Smaller, boutique setting.
Red flags to watch for when evaluating any clinic: No EKG/cardiac screening · No physician or nurse-practitioner on-site · Pressure to decide quickly · Undisclosed pricing · Vague integration support · Claims of "100% success" or "guaranteed cures" · Unwillingness to discuss risks frankly.
vii.

Questions to ask any clinic

Before you commit
1.
Who is the on-site medical director and what are their credentials?
If you can't get a specific name and verifiable credentials, leave.
2.
What cardiac screening do you require before treatment?
Expected answer: EKG, Echo, electrolyte panel. If they skip any of these, leave.
3.
What's your emergency protocol if QT prolongation becomes dangerous?
A real answer involves crash cart, defibrillator, and immediate hospital transfer plan. Vague answers = red flag.
4.
Have you treated 7-OH / kratom cases specifically?
Most clinics have treated some kratom cases, but experience varies. Ask how many, and what outcomes they've seen.
5.
What does your integration program look like post-treatment?
Integration determines outcome. If they wave their hands and say "ongoing support," press for specifics: how many sessions, for how long, with whom.
6.
What's the total cost and what exactly is included?
Lodging, meals, medical screening, the treatment itself, integration, medications, airport transfers. Get it in writing.
7.
Can I speak to former patients who are willing to share their experience?
Reputable clinics can connect you with graduates. If they won't or can't, that tells you something.
8.
What happens if I relapse after treatment?
Listen for: normalization, continued support offered, no shame language. Avoid: anything suggesting a relapse means you "wasted the treatment."